Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Dimension Therapeutics, Inc. | dmtx-ex321_600.htm |
| EX-31.2 - EX-31.2 - Dimension Therapeutics, Inc. | dmtx-ex312_598.htm |
| EX-31.1 - EX-31.1 - Dimension Therapeutics, Inc. | dmtx-ex311_599.htm |
| EX-21.1 - EX-21.1 - Dimension Therapeutics, Inc. | dmtx-ex211_601.htm |
| EX-10.18 - EX-10.18 - Dimension Therapeutics, Inc. | dmtx-ex1018_766.htm |
| EX-10.11 - EX-10.11 - Dimension Therapeutics, Inc. | dmtx-ex1011_765.htm |
| 10-K - FORM 10-K - Dimension Therapeutics, Inc. | dmtx-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8 (No. 333-211502, No. 333-207835) and S-3 (No. 333-214539) of Dimension Therapeutics, Inc. of our report dated March 9, 2017 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
March 9, 2017